Navigation Links
Contemporary Therapeutic Guidelines For HIV Patients

In its quest to vanquish the big time killer AIDS/ HIV infection worldwide Center for AIDS Research at Case Medical Center spearheaded// by Dr Benigno Rodriguez M.D and his extensive team of experts on AIDS/HIV in the U. S. have presented their latest findings in the current issue of Journal Of American Medical Association. Current therapeutic guidelines have been questioned by the latest findings, which contest that the measurement of HIV particles in the blood does not necessarily assess patient’s capability to resist the disease. The current study reiterates the amount of HIV particles (referred to as “viral load” in medical terminology) is not solely to be banked on to assess the rate at which the much valued CD4 cells essential to fight the infection is depleted from the body as a sequel to infection as previously understood.

CD4 cells are white blood cells in the human body, which has a defensive role against invading infection-causing agents. When these cells come under the attack of Human Immunodeficiency Virus, their numbers decline. Following this the symptoms associated with AIDS become more pronounced. The study conducted elucidates that the viral load could account for only 5% of variations in CD4 loss from patient to patient. Therefore it was concluded that the viral load couldn’t be held as sole culprit responsible for bringing down the CD4 count.

Source-Eurekalert
RM
'"/>




Page: 1

Related medicine news :

1. Understanding Chronic Infections May Help in Developing Therapeutic Vaccines
2. Therapeutic cloning by regenerating stem cells from heart muscles
3. Therapeutic Genes Transferred By Viral Vector Through T Cell Masking
4. Therapeutic Monoclonal Antibody Production Is More Profitable Than Small Molecule Drugs
5. Functional Differences In Estrogen Receptor Could Be A Therapeutic Target
6. Clinical-trials Show Increased Therapeutic Activity of Pycnogenol than Daflon
7. Safety of Cancer Therapeutic Viruses Enhanced
8. Researchers Enhance Safety and Effectiveness of Therapeutic Virus that Fights Cancer
9. Human Embryonic Stem Cells Could Be Later Used In Therapeutic Cloning
10. Potential New Therapeutic Target for Asthma, Allergies and Cancer
11. VBI Provides Potential Targets to Diabetes Therapeutics
Post Your Comments:
(Date:12/2/2008)... As the International Day ... Ships celebrates with the story of a young boy bo...ies onboard the Africa Mercy, a floating hospital ...ow and he can run and play with the other children...e downloaded at www.mercyshipsnewsroom.org , ...
(Date:12/2/2008)... Orion Health announces th... (SEARHC) of Juneau, Alaska, has selected the Rhap...nt electronic health record, radiology, pharmacy, ...each other. It also plans to extend connectivity t...Alaska immunization registry) and AKAIMS (an MIS a...
(Date:12/2/2008)...ARIS, Dec. 2 Motorola, I...plemented its T2 powerbroadband system to enable,...e healthcare provider,Generale de Sante to deliv...,Motorola solution provides an advanced IP broadba...delivered over the existing telephone line, elimin...
(Date:12/1/2008)...OUTH BEND, Ind., Dec. 2 Patient sa...ities are on the rise according to a new report,f...ent Pulse Report: Patient,Perspectives on America...acilities as a driver for improvement in patient s... than 2 million patients treated at more than,1,2...
Breaking Medicine News(10 mins):Health News:Mercy Ships Recognizes International Day of Disabled Persons 2Health News:Mercy Ships Recognizes International Day of Disabled Persons 3Health News:SouthEast Alaska Regional Health Consortium Selects Orion Health's Rhapsody Integration Engine for Full-scale Application Integration and Monitoring 2Health News:SouthEast Alaska Regional Health Consortium Selects Orion Health's Rhapsody Integration Engine for Full-scale Application Integration and Monitoring 3Health News:Motorola Extends the Delivery of Personalized Media Experiences to Hospital Group Generale De Sante 2Health News:Motorola Extends the Delivery of Personalized Media Experiences to Hospital Group Generale De Sante 3Health News:Outpatient Service Facilities Face Increasing Competition - Patient Perceptions More Important Than Ever 2
...es Inc. today announced that Mylan Pharmaceuticals.... Food and Drug Administration (FDA) for its Abbr... Hydrochloride Extended-release Tablets, 12.5 mg a...o receive final approval on June 29, 2007, concurr...
...report released today documents the explosive grow...t more than 200 million people are now protected b...nd public places. The report concludes that the mo...accelerating because a global treaty ratified by 1...
...Technologies, Inc. (NTI) announced today the prese...l trials of ancrod and updates on the clinical de...TM) (ancrod), for the treatment of acute ischaemic...ss in Glasgow, Scotland in the United Kingdom. Vip...
... the number two killer in our nation, Americans ar...n fact, according to a recent nationwide survey sp... the scientific community is winning the war again...arching new options to fight cancer, Abbott is ho...
Other Medicine News:Health News:Growth of Smoke-Free Air Laws Worldwide; More Than 200 Million Found "Fully Protected" 2Health News:Investigational Drug Being Pursued for the Treatment of Ischaemic Stroke 2Health News:Americans Optimistic About the War on Cancer 2
(Date:12/1/2008)...as announced that an oral,presentation of prelim...al,trial of TG101348 in myeloproliferative diseas...n Society of Hematology (ASH) Meeting. , , ... Title: A Phase I Study of TG101348, ...K2-Selective Inhibitor, in Patients with, ...
(Date:12/1/2008)... ENB-0040 at Children,s Hospital, Health Sciences ...Newswire/ -- Enobia Pharma, an emerging Canadian b...utics for serious bone disorders, today announced ...ram for hypophosphatasia was dosed. Enobia is inve...B-0040 for the treatment of this rare and often cr...
(Date:12/1/2008)...rstCall/ -- Genaera Corporation (Nasdaq: GENR )... in study MSI-1436C-102 (Study 102), the multiple ...I-1436) in overweight and obese type 2 diabetics. ...of type 2 diabetes and obesity which works central... pathways through the highly selective inhibition ...
(Date:12/1/2008)...oVax Labs, Inc.,(OTC Bulletin Board: GOVX), an At...n vaccines for diseases caused by HIV-1 (Human Imm... announced today that the launch of its Phase 2a H...es across North and South America.,These trials a...stitutes of,Health (NIH), and the HIV Vaccine Tri...
Breaking Medicine Technology:Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3Statins Lower Risk of Clots in Cancer Patients 27771 1Statins Lower Risk of Clots in Cancer Patients 27771 2The mental health dangers of birth hypoxia 27768 1The mental health dangers of birth hypoxia 27768 2Publication on Tregitopes in Blood Journal of October 2008 8613 1Publication on Tregitopes in Blood Journal of October 2008 8613 2Care Improvement Plus Launches 2009 Benefits in Missouri 27763 1Care Improvement Plus Launches 2009 Benefits in Missouri 27763 2
... MRO™-2005 Rigid Percutaneous Nephroscopes c...g throughput capacity with proven MRO performance....ls with small size sheaths. The MRO™-20 shea...oning during percutaneous procedures. The molded b...
...scope, with a stainless steel shaft, combines high...he lumbotome, for precise pre-cutting of scar tiss...fer access. The 13.5 Fr. oval working channel acco... and lithotripsy probes, and allows a high irrigat...
The Olympus SurgMaster OES Pro Resectoscope is based on the award winning Olympus OES Pro standard resectoscope and enables the surgeon to perform TURis - resection in saline. Only by exchanging the
...l drainage from the ureteropelvic junction to the ... ease of placement and patient compliance. The ste...ositioning and ease of removal. AQ® is a micro...ted, attracts and holds water and other liquids to...
Medicine Products: